Search for: "WYETH, INC."
Results 821 - 840
of 877
Sorted by Relevance
|
Sort by Date
18 Jan 2007, 7:53 pm
Pfizer Inc., No. [read post]
5 Feb 2009, 12:19 pm
Pfizer, Inc., 381 F. [read post]
16 Jun 2011, 12:58 pm
Wyeth, 705 S.E.2d 828 (W. [read post]
15 Feb 2010, 2:20 pm
Opinion below (7th Circuit) Petition for certiorari Brief in opposition Petitioner’s reply Title: Rose Acre Farms, Inc. v. [read post]
28 Apr 2009, 7:14 am
Wall to Wall Residence Repairs, Inc. [read post]
20 Jun 2008, 8:07 am
: (IP finance), Technical assistance a key point of discussion at TRIPS Council: (Intellectual Property Watch), WIPO turmoil as new DG’s future comes under threat: (IAM), WIPO to host inter-regional forum to explore strategies to enhance development and service-orientation of IP offices: (WIPO), Controversy over lack of transparency and overreaching enforcement provisions in ACTA: (Spicy IP), (Spicy IP) Global - Trade Marks / Domain Names / Brands World anti-counterfeiting day:… [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is objecting… [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey shows most Americans… [read post]
30 Jul 2013, 2:01 pm
Lexis 1688, at *25-26 n.8 (citing Wyeth v. [read post]
12 Sep 2013, 7:37 am
So we’ve decided to take the plunge.We don’t have much quarrel with Dean Chemerinsky’s initial observation that the existing regime for preemption and prescription drug product liability litigation, fashioned by the trilogy of Wyeth v. [read post]
10 Apr 2014, 11:58 am
Janssen Pharmaceuticals, Inc., 2014 WL 1335511 (Pa. [read post]
23 Mar 2012, 12:53 pm
Wyeth, Inc., No. 11–80814 (S.D. [read post]
9 Jun 2011, 10:02 am
Biomet, Inc., 2008 WL 2329132, at *6 (W.D. [read post]
27 Apr 2007, 12:04 pm
By Hal WegnerBefore an overflow hearing room on an internationally available web broadcast, Chairman Howard Berman of the House Judiciary Subcommittee relevant to patents hosted a most informative and candid hearing yesterday afternoon joined by roughly ten of his committee colleagues, including Rep. [read post]
16 Aug 2009, 11:23 am
The best example of the downside of optionality was the sale of United Rentals Inc. where the buyer, Cerberus, unabashedly chose to pay the break fee rather than close, despite the absence of any material problem in the URI business. [read post]
6 May 2010, 4:12 pm
Metabolife International, Inc., 401 F.3d 1233, 1247 (11th Cir. 2005); Goebel v. [read post]
27 Jun 2008, 10:04 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
6 Jun 2008, 6:49 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
11 Mar 2010, 12:23 pm
Id. at *2.Thus, it didn’t matter what the label said – for this patient, the prescriber in Deitz would not have given a suicide warning.The warning causation facts in Centocor, Inc. v. [read post]
4 Sep 2008, 11:49 am
Apotex, Inc., 521 F.3d 253, 263 (3d Cir. 2008), and those arguments that are before the Supreme Court in the Wyeth v. [read post]
